Top Story

Depression, anxiety increase mortality risk in patients undergoing oral anticoagulation

May 25, 2015

Among outpatients receiving long-term oral anticoagulation, elevated symptoms of depression and anxiety are associated with all-cause mortality, according to research published in the International Journal of Cardiology.

Findings from a study that used a four-item Patient Health Questionnaire (PHQ-4) to assess depression and anxiety underscore the need to implement routine screening procedures and to develop and evaluate psychosocial treatment approaches, according to researchers.

Meeting News Coverage

Obesity may predict bleeding during warfarin treatment

May 25, 2015
Adults with obesity have an elevated risk for bleeding while assigned warfarin therapy compared with adults who are normal weight, researchers reported at the American…
VIDEO: Discussion continues on maintenance of certification in intervention cardiology Meeting News CoverageVideo

VIDEO: Discussion continues on maintenance of certification in intervention cardiology

May 24, 2015
SAN DIEGO — In this video, Charles E. Chambers, MD, FSCAI, interventional cardiologist from Penn State Hershey Heart and Vascular Institute and immediate past…

Edwards temporarily halts transcatheter mitral valve replacement clinical program

May 23, 2015
Edwards Lifesciences announced that it has implemented a temporary pause in enrollment in its Fortis clinical program for development of a transcatheter mitral valve…
Michael R. Zile, MD Meeting News CoveragePerspective

Baroreflex activation therapy may benefit HF patients without CRT

May 22, 2015
BOSTON — For patients with HF who underwent baroreflex activation therapy, the magnitude of effect was greater in those without a chronic resynchronization therapy…
More News Headlines »
CME
Examining Diverse Patient Populations and Their Response to Therapy

Examining Diverse Patient Populations and Their Response to Therapy

This activity is supported by an educational grant from Daiichi Sankyo, Inc. and Lilly USA, LLC

Acute coronary syndrome (ACS) can result in substantial morbidity or death. To reduce the risk of cardiovascular death…
More »
Meeting News Coverage Video
VIDEO: Risk-assessment algorithm may help cardiologists tailor antiplatelet medication

VIDEO: Risk-assessment algorithm may help cardiologists tailor antiplatelet medication

May 18, 2015
SAN DIEGO — Jaya Chandrasekhar, MBBS, an interventional cardiologist and senior clinical research fellow at the…
More »
CME
Antiplatelet Therapy in ACS and PCI

Antiplatelet Therapy in ACS and PCI

This activity is supported by an educational grant from Daiichi Sankyo, Inc. and Lilly USA, LLC.

It is estimated that in the United States, each year, over 780,000 persons will experience an acute coronary syndrome…
More »